Survey of Ophthalmology
Volume 47, Supplement 1 , Pages S90-S96, August 2002

The Effect of Latanoprost on Circadian Intraocular Pressure

  • Lill-Inger Larsson, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint address: Lill-Inger Larsson, MD, PhD, Department of Ophthalmology, Uppsala University Hospital, S-751 85 Uppsala, Sweden.
    • Department of Ophthalmology, Uppsala University Hospital, Uppsala, Sweden
  • ,
  • Hiromu K Mishima, MD

      Affiliations

    • Department of Ophthalmology, Hiroshima University School of Medicine, Hiroshima, Japan
  • ,
  • Michiya Takamatsu, MD

      Affiliations

    • Department of Ophthalmology, Hiroshima University School of Medicine, Hiroshima, Japan
  • ,
  • Nicola Orzalesi, MD

      Affiliations

    • Eye Clinic, Institute of Biomedical Sciences, San Paolo Hospital, University of Milan, Milan, Italy
  • ,
  • Luca Rossetti, MD

      Affiliations

    • Eye Clinic, Institute of Biomedical Sciences, San Paolo Hospital, University of Milan, Milan, Italy

Abstract 

The presence of a circadian variation of both intraocular pressure (IOP) and aqueous humor flow has been demonstrated in several studies. It must therefore be considered important to monitor IOP and evaluate the efficacy of ocular hypotensive drugs over the 24 hours of the day. The efficacy of latanoprost on IOP during both day and night has been evaluated and the most important results from four such studies are reviewed. The studies reviewed here clearly demonstrate that topical administration of latanoprost 0.005% once daily provided a steady reduction of the IOP during both day and night. Given as a single dose to healthy volunteers, latanoprost resulted in a sustained effect with a significant IOP reduction over 24 hours, and the reduction was still present, however less pronounced, even after 48 hours. Latanoprost administered once daily for 4 weeks to patients with glaucoma or ocular hypertension was more effective in reducing the IOP over 24 hours than timolol gel solution 0.5% once daily, timolol aqueous solution 0.5% twice daily, or dorzolamide 2% three times daily. Latanoprost applied once daily thus provided a better effect on the IOP together with a stable and sustained IOP reduction during both day and night.

Keywords:  circadian, diurnal, intraocular pressure, latanoprost, nocturnal, timolol

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Larsson is a consultant to Pharmacia Corp. Three of the four studies that were reviewed in the article had financial support from Pharmacia Corp. The authors reported no financial or proprietary interest in any concepts discussed or products mentioned in the article.

PII: S0039-6257(02)00296-5

Survey of Ophthalmology
Volume 47, Supplement 1 , Pages S90-S96, August 2002